|
注册号: Registration number: |
ChiCTR2300074848 |
|
最近更新日期: Date of Last Refreshed on: |
2024-01-10 22:34:02 |
|
注册时间: Date of Registration: |
2023-08-17 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于具身虚拟镜像视觉反馈理论的“音乐—吞咽”训练对脑干卒中后吞咽功能及情绪状态影响的临床随机对照研究 |
|
Public title: |
A clinical randomized controlled study of "music swallowing" training based on near-infrared brain function imaging technology and embodied virtual mirror visual feedback theory on swallowing function and emotional state after brainstem stroke |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于具身虚拟镜像视觉反馈理论的“音乐—吞咽”训练对脑干卒中后吞咽功能及情绪状态影响的临床随机对照研究 |
|
Scientific title: |
A clinical randomized controlled study of "music swallowing" training based on near-infrared brain function imaging technology and embodied virtual mirror visual feedback theory on swallowing function and emotional state after brainstem stroke |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
甘莉 |
研究负责人: |
甘莉 |
|
Applicant: |
Gan Li |
Study leader: |
Gan Li |
|
申请注册联系人电话: Applicant telephone: |
+86 158 2813 2037 |
研究负责人电话:
Study leader's |
+86 158 2813 2037 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
2388373274@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
2388373274@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
四川省成都市永宁镇八一路81号 |
研究负责人通讯地址: |
四川省成都市永宁镇八一路81号 |
|
Applicant address: |
81 Bayi Road, Yongning Town, Chengdu, Sichuan |
Study leader's address: |
81 Bayi Road, Yongning Town, Chengdu, Sichuan |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
四川省八一康复中心 |
||
|
Applicant's institution: |
Sichuan Bayi Rehabilitation Center |
||
|
研究负责人所在单位: |
四川省八一康复中心 |
||
|
Affiliation of the Leader: |
Sichuan Bayi Rehabilitation Center |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
CKLL-2022013 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
四川省八一康复中心(四川省康复医院)医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Sichuan Bayi Rehabilitation Center (Sichuan Rehabilitation Hospital) |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-07-26 00:00:00 | ||
|
伦理委员会联系人: |
阎晶璐 |
||
|
Contact Name of the ethic committee: |
Yan Jinglu |
||
|
伦理委员会联系地址: |
四川省成都市永宁镇八一路81号 |
||
|
Contact Address of the ethic committee: |
81 Bayi Road, Yongning Town, Chengdu, Sichuan |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 158 2813 2037 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
四川省八一康复中心 |
||||||||||||||||||||||
|
Primary sponsor: |
Sichuan Bayi Rehabilitation Center |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
四川省成都市永宁镇八一路81号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
81 Bayi Road, Yongning Town, Chengdu, Sichuan |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹+项目基金 |
||||||||||||||||||||||
|
Source(s) of funding: |
Raised Independently + Project Fund |
||||||||||||||||||||||
|
研究疾病: |
脑卒中 |
||||||||||||||||||||||
|
Target disease: |
Stroke |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
提高脑干卒中后吞咽障碍患者的康复效果,并推广一套具有广泛实用性的脑干卒中后吞咽障碍患者的治疗处方,以期为进行个体化康复治疗与情绪干预提供方案。 |
||||||||||||||||||||||
|
Objectives of Study: |
To improve the rehabilitation effect of swallowing disorders after brainstem stroke and promote a set of widely practical treatment prescriptions for brainstem stroke swallowing disorders, to provide a plan for personalized rehabilitation treatment and emotional intervention. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.伴有心肺功能代偿不全、传染性疾病、发热、身体极度衰弱和各种出血倾向者,近一周癫痫大发作者; 2.多发脑梗死病灶,皮质、小脑、丘脑等部位病灶; 3.既往有脑出血、蛛网膜下 腔出血、脑肿瘤、脑外伤及其他神经精神系统病史; 4.既往鼻咽癌放疗、头颈癌病变患者; 5.既往有吞咽困难病史;合并有认知功能障碍、失语; 6.有严重心肺肾并发症; 7.不能配合检查与治疗者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Individuals with decompensated cardiovascular function, infectious diseases, fever, extreme physical weakness, and various bleeding tendencies, who have experienced a major outbreak of epilepsy in the past week; 2. Multiple cerebral infarction lesions, including lesions in the cortex, cerebellum, and thalamus; 3. Previous history of cerebral hemorrhage, subarachnoid hemorrhage, brain tumors, traumatic brain injury, and other neurological and psychiatric disorders; 4. Patients with previous nasopharyngeal carcinoma radiotherapy and head and neck cancer lesions; 5. Previous history of swallowing difficulties; Combined with cognitive impairment and aphasia; 6. Having serious cardiovascular, pulmonary, and renal complications; 7. Those who cannot cooperate with the examination and treatment. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-04-18 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-08-28 00:00:00 至 To 2024-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本研究采用区组随机法进行分组,采用 SAS软件在计算机上进行随机编码。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
In this study, block randomization was used for grouping, and SAS software was used for random coding on the computer. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
邮件联系项目负责人取得原始数据。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Contact the project leader via email to obtain the original data. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
研究人员进行数据收集并管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Researchers collect and manage data. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |